Chronic Lymphocytic Leukemia/ Small Lymphocytic Lymphoma, Version 2.2024

被引：8

作者：

Wierda, William G. ^{[1
]}

Brown, Jennifer ^{[2
]}

Abramson, Jeremy S. ^{[3
]}

Awan, Farrukh ^{[4
]}

Bilgrami, Syed F. ^{[5
]}

Bociek, Greg ^{[6
]}

Brander, Danielle ^{[7
]}

Cortese, Matthew ^{[8
]}

Cripe, Larry ^{[9
]}

Davis, Randall S. ^{[10
]}

Eradat, Herbert ^{[11
]}

Fakhri, Bita ^{[12
]}

Fletcher, Christopher D. ^{[13
]}

Gaballa, Sameh ^{[14
]}

Hamid, Muhammad Saad ^{[15
]}

Hill, Brian ^{[16
]}

Kaesberg, Paul ^{[17
]}

Kahl, Brad ^{[18
]}

Kamdar, Manali ^{[19
]}

Kipps, Thomas J. ^{[20
]}

Ma, Shuo ^{[21
]}

Mosse, Claudio ^{[22
]}

Nakhoda, Shazia ^{[23
]}

Parikh, Sameer ^{[24
]}

Schorr, Andrew

Schuster, Stephen ^{[25
]}

Seshadri, Madhav ^{[26
]}

Siddiqi, Tanya ^{[27
]}

Stephens, Deborah M. ^{[28
]}

Thompson, Meghan ^{[29
]}

Ujjani, Chaitra ^{[30
]}

Valdez, Riccardo ^{[31
]}

Wagner-Johnston, Nina ^{[32
]}

Woyach, Jennifer A. ^{[33
]}

Sundar, Hema ^{[34
]}

Dwyer, Mary ^{[34
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Dana Farber Brigham & Womens Canc Ctr, Boston, MA 02115 USA

[3] Mass Gen Canc Ctr, Waltham, MA USA

[4] UT Southwestern Simmons Comprehens Canc Ctr, Dallas, TX USA

[5] Smilow Canc Hosp, Yale Canc Ctr, New Haven, CT USA

[6] Fred & Pamela Buffett Canc Ctr, Omaha, NE 68105 USA

[7] Duke Canc Inst, Durham, NC USA

[8] Roswell Pk Comprehens Canc Ctr, Buffalo, NY USA

[9] Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN USA

[10] UAB, ONeal Comprehens Canc Ctr, Birmingham, AL USA

[11] UCLA Jonsson Comprehens Canc Ctr, Los Angeles, CA USA

[12] Stanford Canc Inst, Stanford, CA 94305 USA

[13] Univ Wisconsin, Carbone Canc Ctr, Madison, WI USA

[14] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA

[15] Univ Tennessee, St Jude Childrens Res Hosp, Hlth Sci Ctr, Knoxville, TN USA

[16] Cleveland Clin, Univ Hosp Seidman Canc Ctr, Case Comprehens Canc Ctr, Taussing Canc Inst, Cleveland, OH USA

[17] Uc Davis Comprehens Canc Ctr, Davis, AL USA

[18] Washington Univ, Barnes Jewish Hosp, Siteman Canc Ctr, Sch Med, Washington, DC USA

[19] Univ Colorado, Canc Ctr, Aurora, CO 80112 USA

[20] UC San Diego Moores Canc Ctr, La Jolla, CA USA

[21] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Evanston, IL 60208 USA

[22] Vanderbilt Ingram Canc Ctr, Vanderbilt, TN 37232 USA

[23] Fox Chase Canc Ctr, Oreland, PA USA

[24] Mayo Clin, Comprehens Canc Ctr, Rochester, MN USA

[25] Univ Penn, Abramson Canc Ctr, Philadelphia, PA USA

[26] UCSF Helen Diller Family Comprehens Canc Ctr, San Francisco, CA USA

[27] City Hope Natl Med Ctr, Duarte, CA USA

[28] Univ Utah, Huntsman Canc Inst, Salt Lake City, UT USA

[29] Mem Sloan Kettering Canc Ctr, New York, NY USA

[30] Fred Hutchinson Canc Ctr, Seattle, WA USA

[31] Univ Michigan, Rogel Canc Ctr, Ann Arbor, MI USA

[32] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21287 USA

[33] Ohio State Univ, Solove Res Inst, James Canc Hosp, Comprehens Canc Ctr, Columbus, OH USA

[34] Natl Comprehens Canc Network, Rockledge, PA USA

来源：

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK | 2024年 / 22卷 / 03期

关键词：

MINIMAL RESIDUAL DISEASE; STEM-CELL TRANSPLANTATION; HIGH-DOSE METHYLPREDNISOLONE; PROGRESSION-FREE SURVIVAL; PREVIOUSLY UNTREATED PATIENTS; CLINICAL END-POINTS; TERM-FOLLOW-UP; V-H GENES; OPEN-LABEL; PHASE-II;

D O I：

10.6004/jnccn.2024.0018

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL) are essentially different manifestations of the same disease that are similarly managed. A number of molecular and cytogenetic variables with prognostic implications have been identi fied. Undetectable minimal residual disease at the end of treatment with chemoimmunotherapy or venetoclax-based combination regimens is an independent predictor of improved survival among patients with previously untreated or relapsed/refractory CLL/SLL. The selection of treatment is based on the disease stage, presence or absence of del(17p) or TP53 mutation, immunoglobulin heavy chain variable region mutation status, patient age, performance status, comorbid conditions, and the agent 's toxicity pro file. This manuscript discusses the recommendations outlined in the NCCN Guidelines for the diagnosis and management of patients with CLL/SLL.

引用

页码：175 / 204

页数：30

共 50 条

[1] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020
Wierda, William G.
Byrd, John C.
Abramson, Jeremy S.
Bilgrami, Syed F.
Bociek, Greg
Brander, Danielle
Brown, Jennifer
Chanan-Khan, Asher A.
Chavez, Julio C.
Coutre, Steve E.
Davis, Randall S.
Fletcher, Christopher D.
Hill, Brian
Kahl, Brad S.
Kamdar, Manali
Kaplan, Lawrence D.
Khan, Nadia
Kipps, Thomas J.
Lim, Megan S.
Ma, Shuo
Malek, Sami
Mato, Anthony
Mosse, Claudio
Shadman, Mazyar
Siddiqi, Tanya
Stephens, Deborah
Sundaram, Suchitra
Wagner, Nina
Dwyer, Mary
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2020, 18 (02): : 185 - 217
[2] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 1.2015
Zelenetz, Andrew D.
Gordon, Leo I.
Wierda, William G.
Abramson, Jeremy S.
Advani, Ranjana H.
Andreadis, C. Babis
Bartlett, Nancy
Byrd, John C.
Czuczman, Myron S.
Fayad, Luis E.
Fisher, Richard I.
Glenn, Martha J.
Habermann, Thomas M.
Harris, Nancy Lee
Hoppe, Richard T.
Horwitz, Steven M.
Kelsey, Christopher R.
Kim, Youn H.
Krivacic, Susan
LaCasce, Ann S.
Nademanee, Auayporn
Porcu, Pierluigi
Press, Oliver
Rabinovitch, Rachel
Reddy, Nishitha
Reid, Erin
Saad, Ayman A.
Sokol, Lubomir
Swinnen, Lode J.
Tsien, Christina
Vose, Julie M.
Wilson, Lynn
Yahalom, Joachim
Zafar, Nadeem
Dwyer, Mary
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2015, 13 (03): : 326 - +
[3] Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 3.2022 Featured Updates to the NCCN Guidelines
Wierda, William G.
Brown, Jennifer
Abramson, Jeremy S.
Awan, Farrukh
Bilgrami, Syed F.
Bociek, Greg
Brander, Danielle
Chanan-Khan, Asher A.
Coutre, Steve E.
Davis, Randall S.
Eradat, Herbert
Fletcher, Christopher D.
Gaballa, Sameh
Ghobadi, Armin
Hamid, Muhammad Saad
Hernandez-Ilizaliturri, Francisco
Hill, Brian
Kaesberg, Paul
Kamdar, Manali
Kaplan, Lawrence D.
Khan, Nadia
Kipps, Thomas J.
Ma, Shuo
Mato, Anthony
Mosse, Claudio
Schuster, Stephen
Siddiqi, Tanya
Stephens, Deborah M.
Ujjani, Chaitra
Wagner-Johnston, Nina
Woyach, Jennifer A.
Ye, J. Christine
Dwyer, Mary A.
Sundar, Hema
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2022, 20 (06): : 622 - 634
[4] Chronic lymphocytic leukemia and small lymphocytic lymphoma: two faces of the same disease
Tees, Michael T.
Flinn, Ian W.
EXPERT REVIEW OF HEMATOLOGY, 2017, 10 (02) : 137 - 146
[5] Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia and small lymphocytic lymphoma from Chronic Lymphocytic Leukemia Spanish Group (GELLC)
Medina, Angeles
Muntanola, Ana
Crespo, Marta
Ramirez, Angel
Hernandez-Rivas, Jose-angel
Abrisqueta, Pau
Alcoceba, Miguel
Delgado, Julio
de la Serna, Javier
Espinet, Blanca
Gonzalez, Marcos
Loscertales, Javier
Serrano, Alicia
Terol, Maria Jose
Yanez, Lucrecia
Bosch, Francesc
MEDICINA CLINICA, 2025, 164 (06): : e1 - e18
[6] Underrepresentation of Small Lymphocytic Lymphoma in Clinical Trials for Chronic Lymphocytic Leukemia
Puckrin, Robert
Owen, Carolyn
Peters, Anthea
EUROPEAN JOURNAL OF HAEMATOLOGY, 2025, 114 (04) : 636 - 640
[7] The expanding role of venetoclax in chronic lymphocytic leukemia and small lymphocytic lymphoma
Schieber, Michael
Ma, Shuo
BLOOD AND LYMPHATIC CANCER-TARGETS AND THERAPY, 2019, 9 : 9 - 17
[8] Ofatumumab and bendamustine in previously treated chronic lymphocytic leukemia and small lymphocytic lymphoma
Ujjani, Chaitra
Ramzi, Pari
Gehan, Edmund
Wang, Hongkun
Wang, Yiru
Cheson, Bruce D.
LEUKEMIA & LYMPHOMA, 2015, 56 (04) : 915 - 920
[9] Initial therapy of chronic lymphocytic leukemia
Eichhorst, Barbara
Cramer, Paula
Hallek, Michael
SEMINARS IN ONCOLOGY, 2016, 43 (02) : 241 - 250
[10] Evaluating zanubrutinib for the treatment of adults with chronic lymphocytic leukemia or small lymphocytic lymphoma
Javidi-Sharifi, Nathalie
Brown, Jennifer R.
EXPERT REVIEW OF HEMATOLOGY, 2024, 17 (06) : 201 - 210

← 1 2 3 4 5 →